In this issue of Acta Physiologica, Ribon-Demars et al. 1 report that exogenous oestradiol administration mitigates vascular oxidative stress and elevated blood pressure in an ovariectomized rat model of sleep-disordered breathing. Sleep apnoea is a major public health issue. If untreated, it leads to premature death. Obstructive sleep apnoea, the most prevalent form of sleep-disordered breathing, is very common, but remains under-diagnosed. The underlying causes of disordered breathing during sleep 2 relate to aberrant airway anatomy as a primary driver, and additional physiological traits such as inadequate function and control of the upper airway muscles; increased likelihood of awakening during airway obstruction (low arousal threshold); and respiratory control instability (increased loop gain). Narrowing or occlusion of the upper airway arises from sleep-related reductions in the motor drive to the pharyngeal muscles, which are pivotal in the control of upper airway calibre and collapsibility. This natural state-dependent reduction in cranial nerve activity is problematic for a majority of sleep apnoea patients with at-risk i.e. narrow/collapsible airways. The Wisconsin Sleep Cohort Study 3 established prevalence estimates of moderate-to-severe sleepdisordered breathing at 10% (30-49-year-old men); 17% (50-70-year-old men); 3% (30-49-year-old women); and 9% (50-70 year-old women). Rather worryingly, the estimated prevalence rates have increased substantially over the last two decades, most likely a reflection of the growing obesity epidemic. Strikingly, the prevalence of sleep apnoea is much greater in men compared with women. However, progression through menopause is associated with greater severity of sleep-disordered breathing, independent of aging and changes in body habitus, 4 such that prevalence estimates are generally equivalent between post-menopausal women and age-matched males, revealing the critical influence of sex hormones in the propensity for the development of sleep apnoea.
The disruptive and harmful sequelae of the sleep apnoea syndrome can include excessive daytime sleepiness, neurocognitive impairments, metabolic dysregulation, and overt cardiovascular morbidity. Evidence points to a strong link between sleep apnoea and cardiac dysrhythmia, coronary artery disease, heart failure, vascular endothelial dysfunction, increased risk of stroke and vascular dementia, and most compellingly, hypertension 5 , albeit with some reservations. Repeated occlusions of the upper airways evoke pressor responses and nocturnal hypertension. Strikingly, in many persons with sleep apnoea blood pressure is elevated during the daytime associated with persistent diurnal sympathetic nervous system over-activity. The reductions or cessations in pulmonary airflow
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This article is protected by copyright. All rights reserved. associated with periodic occlusions of the upper airways during sleep in apnoeic patients result in arterial blood gas derangements, seen clinically as episodic arterial blood deoxygenation followed by reoxygenation resulting from restoration of airflow. Thus, long-term exposure to chronic intermittent hypoxia (CIH) is a cardinal feature of the sleep apnoea syndrome, and is sufficient to cause symapthoexcitation and elevated blood pressure in human subjects and various animal models.
In the comprehensive and carefully-conducted studies by Ribon-Demars et al., 1 adult female rats were exposed to normoxia or CIH, modelling mild sleep apnoea; subsets of rats within these two groups underwent sham surgery or were ovariectomized with subsequent chronic vehicle or chronic 17β oestradiol administration. Exposures to IH lasted 7 or 35 days allowing the comparison of responses in the period of the development of cardiovascular morbidity (days) and its relatively prolonged maintenance (weeks); outcomes which may depend on different driving mechanisms. Blood pressure, heart rate and plasma endothelin-1 levels (a potent vasoconstrictor) were determined, accompanied by assessments of thoracic aorta reactivity and oxidant status. The study design allowed for the consideration of important questions: What are the cardiovascular consequences of exposure to CIH over varying time domains in the presence and absence of ovarian steroid hormones? Does 17β oestradiol treatment ameliorate hypertension and vascular oxidative stress and dysfunction in ovariectomized rats during normoxia and CIH? This broad vista is a notable strength of the study---an important area of investigation in the context of cardiovascular risk in perimenopausal women with and without sleep-disordered breathing.
Exposure to IH raised blood pressure after 7 and 35 days in sham and ovariectomized rats; tachycardia and increased plasma endothelin-1 levels were evident during early hypoxic stress, but values were equivalent to respective control levels after several weeks' exposure. 17β oestradiol treatment ameliorated hypertension in IH exposed rats, but blood pressure remained elevated, a result of ovariectomy per se, which was not amenable to 17β oestradiol treatment. In rats exposed to 7 days of IH, replacement hormone treatment restored heart rate and peripheral endothelin-1 levels. In thoracic aorta samples, the activity of reactive oxygen species generating cytosolic oxidases (NADPH oxidase and xanthine oxidase) was elevated in ovariectomized rats after 7 days, both in normoxia and IH, with attendant increased protein oxidation indicative of oxidative stress. Interestingly, 17β oestradiol treatment reversed aortic oxidative stress in ovariectomized rats, but by mechanisms that differed in normoxic (normal pro-oxidant enzyme activities) and IH exposed animals (abrogated increased glutathione peroxidase activity together with increased catalase but not superoxide dismutase activity). Surprisingly, all measures of oxidant status were equivalent between all groups at 35 days. Contractile responses of aortic rings to phenylephrine were blunted in short-term IH exposed sham but not ovariectomized rats; 17β oestradiol treatment led to potentiated contractile responses to alpha-adrenergic stimulation with phenylephrine. Assessment of vascular relaxation revealed slightly blunted responses to acetylcholine (endothelium-dependent), but not sodium nitroprusside (endothelium-independent), in ovariectomized rats exposed to short-term IH, which was amenable to 17β oestradiol treatment. Vascular reactivity was similar in all groups at 35 days, mirroring the consistency in aortic oxidant:antioxidant status parameters at this time point.
The study by Ribon-Demars et al. 1 illustrates that modest IH evokes hypertension in female rats, with no sex advantage or protection as is commonly observed in other forms of experimentallyinduced hypertension. 17β oestradiol treatment ameliorates IH-induced hypertension, which most likely relates to recovery of IH-induced enhanced chemoreflex activation of sympathetic outflow as shown previously by this group 6 . Of note, blood pressure was elevated by ovariectomy per se, and
